Oxford Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-301,218
Closed -$3.72M 751
2024
Q4
$3.72M Buy
+301,218
New +$3.45M 1.65% 2
2024
Q1
Sell
-10,486
Closed -$68.2K 378
2023
Q4
$68.2K Buy
+10,486
New +$67.6K 0.1% 170
2020
Q1
Sell
-264,077
Closed -$2.02M 1391
2019
Q4
$2.02M Buy
264,077
+153,790
+139% +$897K 0.06% 411
2019
Q3
$585K Buy
110,287
+84,118
+321% +$522K 0.01% 1200
2019
Q2
$147K Sell
26,169
-18,849
-42% -$77.7K ﹤0.01% 1587
2019
Q1
$191K Sell
45,018
-343,063
-88% -$1.4M ﹤0.01% 1519
2018
Q4
$1.59M Buy
388,081
+33,974
+10% +$177K 0.04% 598
2018
Q3
$2.42M Buy
354,107
+307,721
+663% +$1.82M 0.05% 550
2018
Q2
$182K Sell
46,386
-43,517
-48% -$151K ﹤0.01% 1598
2018
Q1
$263K Buy
89,903
+14,526
+19% +$44.9K 0.01% 1434
2017
Q4
$300K Buy
75,377
+1,860
+3% +$7.97K 0.01% 1332
2017
Q3
$231K Buy
+73,517
New +$276K ﹤0.01% 1393
2013
Q3
Sell
-22,982
Closed -$208K 915
2013
Q2
$208K Buy
+22,982
New +$241K 0.01% 787

Other funds holding CDMO

Oxford Asset Management's CDMO Position: Q1 2025 in Review

Oxford Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 301,218 shares — an estimated $3.72M sold.

Oxford Asset Management first reported a position in CDMO in Q2 2013 and held it in 13 quarters. The position peaked at $3.72M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Oxford Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Oxford Asset Management sold 301,218 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.72M.
  • Oxford Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • Oxford Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $3.72M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Oxford Asset Management's 13F filing for Q1 2025, filed 15 May 2025.